Chemclin Diagnostics Co., Ltd. (SHSE: 688468)
Health Care · Health Care Equipment & Supplies · CN
CN¥6.69
+2.45% today · -13.7% 1Y
Chemclin Diagnostics Co., Ltd. (SHSE: 688468) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $394.12M and employs 573 people.
Over the last twelve months the share price has lost 13.7%, trading between 5.50 and 8.55.
Tweenvest scores Chemclin Diagnostics Co., Ltd. across four factors: quality 79/100, value 27/100, growth 0/100. Its strongest factor is quality.
688468 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $394.12M
- Revenue (TTM)
- $47.48M
- P/E
- 74.43
- EPS
- 0.09
- Dividend yield
- —
- Beta (5Y)
- 0.05
- 52-week high
- CN¥8.55
- 52-week low
- CN¥5.50
- Avg volume (3M)
- —
- Shares outstanding
- 394.59M
- Employees
- 573
- Next earnings
- —
About Chemclin Diagnostics Co., Ltd.
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. The company was founded in 2007 and is headquartered in Beijing, China.
- ISIN
- CNE100005311
- Founded
- 2005
- Listed since
- Apr 9, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shenzhen Bioeasy Biotechnology Co., Ltd.SZSE: 300942 | $400.96M | CN¥6.63 | -0.30% |
| OrbusNeich Medical Group Holdings LimitedSEHK: 6929 | $400.74M | HK$3.82 | +0.66% |
| Peijia Medical LimitedSEHK: 9996 | $396.84M | HK$4.63 | +1.20% |
| Chongqing Xishan Science & Technology Co., Ltd.SHSE: 688576 | $396.68M | CN¥39.55 | -0.75% |
| Carlsmed, Inc.NasdaqGS: CARL | $393.71M | $14.42 | +2.63% |
| CellaVision AB (publ)OM: CEVI | $385.95M | Skr161.80 | -2.06% |
| Jiangsu Apon Medical Technology Co., Ltd.SZSE: 300753 | $381.45M | CN¥20.27 | -1.89% |
| Allgens Medical Technology CO., LTD.SHSE: 688613 | $379.85M | CN¥18.57 | -7.61% |
Figures last refreshed Oct 11, 2026.